Karakaplan, MustafaErtem, KadirPolat, HacıSakçı, Mehmet ŞahOklu, Yunus2020-06-262020-06-262019MUSTAFA K., KADİR E., Hacı P., Mehmet Şah S., Yunus G. (2019). Percutaneous needle aponeurotomy for the treatment of Dupuytren’s contracture, Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), İnönü Üniversitesi, Malatya.1305-82821309-0313https://doi.org/10.5606/ehc.2019.58854https://hdl.handle.net/11616/16108https://search.trdizin.gov.tr/yayin/detay/313649Objectives: This study aims to present the early-period outcomes of patients with Dupuytren’s contracture (DC) treated with percutaneous needle aponeurotomy technique. Patients and methods: This retrospective study included 28 patients (20 males, 8 females; mean age 63 years; range, 44 to 88 years) (75 fingers) treated with percutaneous aponeurotomy due to DC between November 2011 and December 2015. Patients were evaluated according to their demographic characteristics, presence of additional disease, family history, history of drug use, complication rate, recurrence development, postoperative patient satisfaction, reoperational request, postoperative Disability of Arm Shoulder and Hand Questionnaire and visual analog scale scores. Results: Mean follow-up duration was 29 months (range, 12 to 60 months). In the postoperative satisfaction questionnaire, 92.9% (n=26) of patients stated that they were satisfied. In the questionnaire of reoperation request, 82.1% (n=23) of patients accepted the reoperation. While the complication rate was 39.3%, recurrence rate was 35.7%. Conclusion: Percutaneous needle aponeurotomy technique may be an effective, simple, and safe method for the treatment of DC. Keywords: Complications, Dupuytren’s contracture, percutaneous aponeurotomy, reoperation.trinfo:eu-repo/semantics/openAccessCerrahi;OrtopediPercutaneous needle aponeurotomy for the treatment of Dupuytren’s contractureDupuytren kontraktürü tedavisi için perkütan iğne aponörotomiArticle30153603088510910.5606/ehc.2019.588542-s2.0-85063251003N/A313649WOS:000462121500009Q3